Celldex Therapeutics (CLDX) had the highest return between January 1, 1991 and March 31, 1991 by a US stock in the Biotechnology Industry, returning 145.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Celldex Therapeutics (CLDX) | 1/1/1991 - 3/31/1991 | 145.83% |
ImmuCell (ICCC) | 1/1/1991 - 3/31/1991 | 122.22% |
Amgen (AMGN) | 1/1/1991 - 3/31/1991 | 111.7% |
GT Biopharma (GTBP) | 1/1/1991 - 3/31/1991 | 100% |
Compass Therapeutics (CMPX) | 1/1/1991 - 3/31/1991 | 100% |
CEL-SCI (CVM) | 1/1/1991 - 3/31/1991 | 100% |
Heron Therapeuti (HRTX) | 1/1/1991 - 3/31/1991 | 82.35% |
Anixa Biosciences (ANIX) | 1/1/1991 - 3/31/1991 | 80% |
Abeona Therapeutics (ABEO) | 1/1/1991 - 3/31/1991 | 66.67% |
XOMA (XOMA) | 1/1/1991 - 3/31/1991 | 41.98% |
Insmed (INSM) | 1/1/1991 - 3/31/1991 | 3.01% |
Lisata Therapeutics (LSTA) | 1/1/1991 - 3/31/1991 | 0% |
Vera Therapeutics (VERA) | 1/1/1991 - 3/31/1991 | -7.14% |
